7 research outputs found
Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer’s Disease
BACKGROUND: There is a clear need for simple and effective tests to identify individuals who are most likely to develop Alzheimer’s Disease (AD) both for the purposes of clinical trial recruitment but also for improved management of patients who may be experiencing early pre-clinical symptoms or who have clinical concerns. OBJECTIVES: To predict individuals at greatest risk of progression of cognitive impairment due to Alzheimer’s Disease in individuals from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) using a polygenic risk scoring algorithm. To compare the performance of a PRS algorithm in predicting cognitive decline against that of using the pTau/Aß1-42 ratio CSF biomarker profile. DESIGN: A longitudinal analysis of data from the Alzheimer’s Disease Neuroimaging Initiative study conducted across over 50 sites in the US and Canada. SETTING: Multi-center genetics study. PARTICPANTS: 515 subjects who upon entry to the study were diagnosed as cognitively normal or with mild cognitive impairment. MEASUREMENTS: Use of genotyping and/or whole genome sequencing data to calculate polygenic risk scores and assess ability to predict subsequent cognitive decline as measured by CDR-SB and ADAS-Cog13 over 4 years RESULTS: The overall performance for predicting those individuals who would decline by at least 15 ADAS-Cog13 points from a baseline mild cognitive impairment in 4 years was 72.8% (CI:67.9-77.7) AUC increasing to 79.1% (CI: 75.6-82.6) when also including cognitively normal participants. Assessing mild cognitive impaired subjects only and using a threshold of greater than 0.6, the high genetic risk participant group declined, on average, by 1.4 points (CDR-SB) more than the low risk group over 4 years. The performance of the PRS algorithm tested was similar to that of the pTau/Aß1-42 ratio CSF biomarker profile in predicting cognitive decline. CONCLUSION: Calculating polygenic risk scores offers a simple and effective way, using DNA extracted from a simple mouth swab, to select mild cognitively impaired patients who are most likely to decline cognitively over the next four years
Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer’s Disease
This is the final version. Available on open access from Springer Nature via the DOI in this recordBACKGROUND: There is a clear need for simple and effective tests to identify individuals
who are most likely to develop Alzheimer’s Disease (AD) both for the purposes of clinical
trial recruitment but also for improved management of patients who may be experiencing
early pre-clinical symptoms or who have clinical concerns.
OBJECTIVES: To predict individuals at greatest risk of progression of cognitive
impairment due to Alzheimer’s Disease in individuals from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) using a polygenic risk scoring algorithm. To compare the
performance of a PRS algorithm in predicting cognitive decline against that of using the
pTau/Aẞ1-42 ratio CSF biomarker profile.
DESIGN: A longitudinal analysis of data from the Alzheimer’s Disease Neuroimaging
Initiative study conducted across over 50 sites in the US and Canada
SETTING: Multi-center genetics study
PARTICPANTS: 515 subjects who upon entry to the study were diagnosed as cognitively
normal or with mild cognitive impairment
MEASUREMENTS: Use of genotyping and/or whole genome sequencing data to calculate
polygenic risk scores and assess ability to predict subsequent cognitive decline as measured
by CDR-SB and ADAS-Cog13 over 4 years
RESULTS: The overall performance for predicting those individuals who would decline by
at least 15 ADAS-Cog13 points from a baseline mild cognitive impairment in 4 years was
72.8% (CI:67.9-77.7) AUC increasing to 79.1% (CI: 75.6-82.6) when also including
cognitively normal participants. Assessing mild cognitive impaired subjects only and using a
threshold of greater than 0.6, the high genetic risk participant group declined, on average, by
1.4 points (CDR-SB) more than the low risk group over 4 years. The performance of the
PRS algorithm tested was similar to that of the pTau/Aẞ1-42 ratio CSF biomarker profile in
predicting cognitive decline.
CONCLUSION: Calculating polygenic risk scores offers a simple and effective way, using
DNA extracted from a simple mouth swab, to select mild cognitively impaired patients who
are most likely to decline cognitively over the next four yearsNational Institutes of Health (NIH)Department of DefenseInnovate U
Transcriptome and proteome analysis of Salmonella enterica serovar Typhimurium systemic infection of wild type and immune-deficient mice
Salmonella enterica are a threat to public health. Current vaccines are not fully effective. The ability to grow in infected tissues within phagocytes is required for S. enterica virulence in systemic disease. As the infection progresses the bacteria are exposed to a complex host immune response. Consequently, in order to continue growing in the tissues, S. enterica requires the coordinated regulation of fitness genes. Bacterial gene regulation has so far been investigated largely using exposure to artificial environmental conditions or to in vitro cultured cells, and little information is available on how S. enterica adapts in vivo to sustain cell division and survival. We have studied the transcriptome, proteome and metabolic flux of Salmonella, and the transcriptome of the host during infection of wild type C57BL/6 and immune-deficient gp91-/-phox mice. Our analyses advance the understanding of how S. enterica and the host behaves during infection to a more sophisticated level than has previously been reported.This work was supported by a Medical Research Council (MRC) grant G0801161awarded to A.J.G., P.M. and D.J.M. OO was supported by a Newton Trust grant awarded to AJG. MC was supported by an Engineering and Physical Sciences Research Council (EPSRC) doctoral training studentship
Reduction of elementary flux mode complexity enables rational metabolic engineering for biotechnological products
Complete genome for Actinobacillus pleuropneumoniae serovar 8 reference strain 405: comparative analysis with draft genomes for different laboratory stock cultures indicates little genetic variation
We report here the complete genome sequence of the widely studied Actinobacillus pleuropneumoniae serovar 8 reference strain 405, generated using the Pacific Biosciences (PacBio) RS II platform. Furthermore, we compared draft sequences generated by Illumina sequencing of six stocks of this strain, including the same original stock used to generate the PacBio sequence, held in different countries and found little genetic variation, with only three SNPs identified, all within the degS gene. However, sequences of two small plasmids, pARD3079 and p405tetH, detected by Illumina sequencing of the draft genomes were not identified in the PacBio sequence of the reference strain